Albert Invent, a leading innovator in materials science, has announced the successful closure of a $22.5 million Series A funding round. This round was led by Coatue, with additional support from renowned investors such as TCV, Index Ventures, F-Prime, and Homebrew. The funding will fuel the expansion of the company’s engineering team, enhance its platform capabilities, and scale operations globally to meet increasing demand.
Albert Breakthrough™: Revolutionizing Chemistry with AI
In conjunction with the funding announcement, Albert introduced Albert Breakthrough™, the first AI-powered platform specifically tailored for chemists. Breakthrough integrates centralized, structured data with advanced AI to optimize experiments, predict molecular properties, and generate novel formulations. This innovative tool represents a significant milestone in chemical R&D, enabling companies to develop products faster and more efficiently than ever before.
By using Albert Breakthrough, chemical companies can leverage a centralized database of historical experimental data to fuel machine learning models that continuously evolve. The platform offers an intuitive interface, bridging human expertise with machine intelligence, allowing chemists to achieve groundbreaking results.
Key Features of Albert Breakthrough
Breakthrough’s features are designed to address critical pain points in the chemical industry:
- Molecular Predictions: Real-time predictions of molecular properties and toxicology, surpassing traditional models.
- Structure Search: Advanced modeling to identify exact or similar molecular structures.
- Inverse Design: Formulation generation targeting specific performance metrics while adhering to regulatory standards.
- Active Learning: AI models evolve with new experimental data, improving predictions continuously.
- SKU Rationalization: Streamlined product portfolios through the identification of duplicate or similar formulations.
- Model Explainability: Comprehensive insights into the rationale behind AI predictions, including molecular influences and accuracy metrics.
These capabilities empower chemists to accelerate the innovation process, reduce costs, and optimize product development cycles.
Industry-Wide Adoption and Enthusiasm
Albert has rapidly gained traction among industry leaders. Customers such as Chemours, Solenis, Keystone Industries, and Applied Molecules have adopted its platform, while established partners like Henkel and Nouryon have expanded their collaboration. Currently, thousands of scientists worldwide utilize Albert’s solutions to expedite their research and bring products to market more efficiently.
Nicholas Gripp, Senior Chemist at Applied Molecules, expressed optimism about the potential of Albert Breakthrough. “The formulas it proposed during initial tests were impressive. We believe this technology will significantly streamline our formulation process and accelerate our innovation efforts.”
Johan Landfors, CTO of Nouryon, highlighted the transformative potential of the platform. “Albert’s tools have become integral to our product development. With Breakthrough, our scientists can leverage the collective intelligence of past experiments to drive innovation cycles even faster.”
Investor Confidence and Future Vision
David Schneider, General Partner at Coatue, emphasized the importance of modernizing scientific labs. “Scientific labs are the foundation of research and development, and they require constant modernization to keep pace with a rapidly evolving world. Albert’s application of AI to chemical R&D is transforming the industry, creating efficiencies and driving business benefits.”
About Albert Invent
Founded by chemists and backed by prominent investors, Albert Invent’s mission is to accelerate innovation in materials science. Based in Oakland, California, the company provides a cloud-based platform designed for chemistry and materials science professionals. By unifying experimental data and offering AI-driven insights, Albert enables scientists across more than 30 countries to streamline workflows, accelerate product development, and navigate complex regulatory landscapes.
Albert’s end-to-end solution has already delivered significant value to industry leaders, reducing the time and cost associated with bringing new materials and formulations to market.
